FDA Inspection 1171968 — South Texas Blood And Tissue Center
The FDA completed an inspection of South Texas Blood And Tissue Center on Jun 10, 2022 in New Braunfels, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 10, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- New Braunfels, TX (United States)